Clinically Proven Effectiveness
A 2025 IRB-approved pilot study published in PubMed reported no adverse effects following intravenous administration of 20mg in 2 healthy adults, with monitored biomarkers (heart, liver, kidneys, thyroid, and blood glucose) returning normal results
[DOI] [PubMed] [Google Scholar] 190.Aoun L., Almardini S., Saliba F., et al
R., Erny, J., Guba, W
Who Should Avoid Ipamorelin or Sermorelin
Originally developed to treat obesity, AOD9604 selectively targets lipolysis (fat breakdown) without the anabolic or growth-related effects of full-length hGH making it a powerful option for individuals focused purely on body fat reduction, not muscle gain